Chemiluminiscence Imaging or commonly known as CLIA is a doctrine predominantly witnessed in healthcare sector and blotting techniques and its relevance in detection of cancer has been well-documented. Chemiluminiscence transpires or better still molecules of light are emitted when luminol, synthetic compound (C8H7N302) reacts with an oxidizing agent viz hydrogen peroxide. Chemiluminiscence imaging marks its presence in forensic analysis by detecting traces of blood with iron content that emits a blue light under influence of an oxidizing agent or an oxidant.
Yet again, blue light emission states presence of copper cyanide and specific proteins as they come in contact under influence of an oxidant in an observed chemical reaction. Secondary equipment coming in handy is a HD camera for imaging. Chemiluminiscence also is used in biological assays to detect presence of biomolecules and traces of inorganic ions. Luminescence accepts various sequences as biochemical for bioluminescence, photons for photoluminescence and electromagnetic as electroluminescence based on excitation event.
Segmentation of chemiluminiscence imaging market by applications include chemiluminiscence immunoassays, hormones, insulin, thyroxin, estradiol, vitamin Vit 12, tumor markers, DNA hybridization detection, souther blotting, hybridization, western blotting, forensic science, food analysis, find organophosphorus most popular pesticide (Qunalphos).
Segmentation of chemiluminiscence market by region includes North America, Europe, Asia Pacific, MEA and Latin America. North America is foremost player in field of chemiluminescence imaging followed by Europe. The chemiluminiscence market is witnessing a high growth trajectory in North America and Asia pacific with established presence of big players in the field of chemiluminiscence imaging.
Chemiluminiscence is a highly fragmented market with too many players in contention, both local and international. Product launches such as Odyssey launched by LI-COR Biosciences and with uncluttered use in segments across industries such as biological and food analysis market drives growth in chemiluminiscence market. Drivers to the chemiluminiscence market include its preferential use in food, medical and forensic industry and in pre-clinical tests and R& D by research institutes and pharmaceutical laboratories.
Product development has wide scope in research and development laboratories using chemiluminiscence imaging enhancing growth in chemiluminiscence imaging market. As per industry news, chemiluminiscence immunoassays offer best solutions for quantification of low concentration of samples from an ambiguous mixture in comparison to RIA.
The non-radioactive nature of technique is better still in applications ranging from microbiology, Agriculture, therapeutic and clinical segments. CLIA has a better playing field in developed economies such as North America and Europe being a fully automated version. Key industry players in chemiluminiscence imaging market include LI-COR Biosciences, Analytik Jena US, Azure Biosystems, Berthold Technologies GmbH & Co., KG, Syngene, GE Healthcare, Thermo Fischer Scientific, Analytic Jena Life Science and PerkinElmer, Inc.
Research Support Specialist, USA